This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Peijun Zhan: Innovator in Bacterial Strain Development
Introduction
Peijun Zhan is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of microbiology, particularly in the development of bacterial strains with practical applications in medicine.
Latest Patents
Peijun Zhan holds a patent for a bacterial strain named sp. HS-16-20, which is preserved under the CGMCC (China General Microbiological Culture Collection Center) No. 7294. This bacterial strain can be utilized to generate Fidaxomicin or its analogs, as well as compositions containing Fidaxomicin. The process involves aerobically fermenting the strain in a nutrient medium that includes assimilable carbon and/or nitrogen sources. Fidaxomicin is known for its inhibitory effects on various gram-positive bacterial pathogens.
Career Highlights
Zhan is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he applies his expertise in microbiology to advance pharmaceutical innovations. His work focuses on developing effective treatments against bacterial infections, contributing to public health.
Collaborations
Peijun Zhan has collaborated with notable colleagues, including Hua Bai and Hao Xu, to further enhance research and development in his field.
Conclusion
Peijun Zhan's innovative work in bacterial strain development exemplifies the intersection of microbiology and pharmaceutical applications. His contributions are vital in the ongoing fight against bacterial pathogens.